AstraZeneca-Daiichi Sankyo Enhertu approved in China for breast cancer Ruchika Sharma25 Feb 2023 1:30 PM ISTUK: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult...
AstraZeneca Calquence tablet formulation approved in EU for adults with chronic lymphocytic leukaemia Ruchika Sharma23 Feb 2023 11:30 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of Bruton's tyrosine kinase (BTK).
AstraZeneca India gets CDSCO nod for Durvalumab to treat biliary tract cancer Ruchika Sharma17 Feb 2023 12:00 PM ISTNew Delhi: Science-led biopharmaceutical company, AstraZeneca India, has announced additional indication approval from Central Drugs...
Natco Pharma announces submission of ANDA with USFDA for generic version of Olaparib Tablets Ruchika Sharma13 Feb 2023 12:25 PM ISTOlaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer.
Covishield even worse in terms of cardiovascular effects, heart attacks and strokes: Eminent British Indian Cardiologist Roshni Dhar8 Feb 2023 4:39 PM ISTEminent British Indian Cardiologist Dr Aseem Malhotra, who has been leading international calls for the suspension of mRNA COVID 19 vaccines, said on...
Health Bulletin 8/January/2023 Roshni Dhar8 Feb 2023 4:36 PM ISTHere are the top health stories for the day:NEET PG 2023 postponement: Doctors protest at Jantar Mantar Escalating their demand for NEET PG 2023...
Drug companies face COVID cliff in 2023 as sales set to plummet Ruchika Sharma8 Feb 2023 3:27 PM ISTNew York: Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up...
Covishield even worse in terms of cardiovascular effects, heart attacks and strokes, claims leading British Indian Cardiologist Kajal Rajput8 Feb 2023 12:44 PM ISTLeading British Indian Cardiologist claims Covishield “should never have been rolled out in the country in the first place and warns against its major...
AstraZeneca Forxiga approved in EU for treatment of symptomatic chronic heart failure Ruchika Sharma7 Feb 2023 4:15 PM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
USFDA withdraws emergency use authorization for AstraZeneca COVID 19 treatment Evusheld Ruchika Sharma27 Jan 2023 4:42 PM ISTAstraZeneca said it was informed that the agency will decide about reinstating authorization of Evusheld if the prevalence of resistant variants in...
Alembic Pharma bags USFDA nod for mantle cell lymphoma drug Acalabrutinib Ruchika Sharma19 Jan 2023 3:15 PM ISTAcalabrutinib Capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy...
